Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024
NEW YORK, NY, Jan 16, 2023 – (JCN Newswire via SEAPRWire.com) – PCG Digital — Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company, is on track to deliver a safe and effective front-line treatment to a community of patients living with a rare, chronic cancer. [ImaContinue Reading